CD8A and neoplasm: In patients with neoplasms, there is certainly a dysfunction of cell-mediated immunity with a consequent reduction of antitumour immunity, this being the arm of the immune system that constitutes the main antitumour mechanism, particularly by CD8+ cytotoxic T lymphocytes [17].